|
業務類別
|
Biotechnology |
|
業務概覽
|
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform. |
| 公司地址
| 225 NE Mizner Boulevard, Suite 640, Boca Raton, FL, USA, 33432 |
| 電話號碼
| +1 561 710-0512 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.inmunebio.com |
| 員工數量
| 21 |
| Mr. David J. Moss |
President, Chief Executive Officer, Treasurer, Secretary and Director |
美元 405.27K |
30/03/2026 |
| Mr. Cory Randall Ellspermann |
Chief Financial Officer and Principal Accounting Officer |
-- |
30/03/2026 |
| Dr. Mark Lowdell, PhD |
Chief Scientific Officer |
-- |
21/04/2025 |
|
|
| Mr. David J. Moss |
President, Chief Executive Officer, Treasurer, Secretary and Director |
30/03/2026 |
| Ms. Marcia Allen |
Independent Director |
30/03/2026 |
| Mr. J. Kelly Ganjei |
Independent Director |
30/03/2026 |
| Mr. Timothy Schroeder |
Independent Director |
30/03/2026 |
| Mr. Scott Juda, J.D. |
Independent Director |
30/03/2026 |
|
|
|
|
